Paul R. Fonteyne

Companies

• Apnimed, Inc.Board member Jul 30, 2026 to now¹
• Amylyx PharmaceuticalsBoard member Jan 6, 2022 to now²
• Apellis Pharmaceuticals, Inc.Board member Apr 6, 2020 to now³
• COVETRUS, INC.Board member Jul 6, 2021 to Oct 13, 2022⁴
• GelesisBoard member Jan 24, 2022 to May 9, 2022⁵
• AMAG PharmaceuticalsBoard member Oct 10, 2019 to Nov 17, 2020⁶
• Adicet Bio, Inc.Board member Jan 25, 2018 to Jun 5, 2020⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Amylyx Pharmaceuticals AMLX3,947 shares⁸$106.8K at $27.07Jan 6, 2022
• APApellis Pharmaceuticals, Inc.0 shares⁹May 14, 2026
• CCOVETRUS, INC.0 shares¹⁰Oct 13, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Returned to company 3,877 shares of Apellis Pharmaceuticals, Inc.⁹
• May 14, 2026Returned to company 3,544 shares of Apellis Pharmaceuticals, Inc.⁹
• May 14, 2026Returned to company 7,961 shares of Apellis Pharmaceuticals, Inc.⁹
• May 14, 2026Returned to company 5,744 shares of Apellis Pharmaceuticals, Inc.⁹
• May 14, 2026Returned to company 3,062 shares of Apellis Pharmaceuticals, Inc.⁹
• May 14, 2026U 30,666 shares of Apellis Pharmaceuticals, Inc.⁹
• Jan 1, 2026Granted 7,961 shares of Apellis Pharmaceuticals, Inc.¹¹
• Jan 1, 2025Granted 6,267 shares of Apellis Pharmaceuticals, Inc.¹²
• Jan 1, 2024Granted 3,341 shares of Apellis Pharmaceuticals, Inc.¹³
• Jan 1, 2023Granted 3,867 shares of Apellis Pharmaceuticals, Inc.¹⁴
• Oct 13, 2022Returned to company 13,275 shares of COVETRUS, INC.¹⁰
• Jul 1, 2022Exercised options 8,275 shares of COVETRUS, INC.¹⁵
• May 6, 2022Granted 53,832 shares of CIK 1805087¹⁶
• Jan 6, 2022Bought 3,947 shares at $19.00 of Amylyx Pharmaceuticals⁸
• Jan 1, 2022Granted 4,230 shares of Apellis Pharmaceuticals, Inc.¹⁷